November 27, 2019 / 12:37 PM / 14 days ago

IN BRIEF: Federal Circuit orders second look at Prevnar patent’s surviving claim

The U.S. Court of Appeals for the Federal Circuit on Tuesday revived Merck Sharp & Dohme Corp’s challenge to the last surviving claim of a patent underlying Pfizer’s pneumonia vaccine Prevnar 13.

A three-judge Federal Circuit panel overturned a ruling by the U.S. Patent and Trademark’s Office’s Patent Trial Appeal Board upholding the single claim, calling the decision “too cryptic to survive judicial review.”

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below